The rise in Demand for Laser Surgery is Boosting the Growth of the Glaucoma and Cataract Surgery Devices Market During the Forecast Period 2023-2028

The Glaucoma & Cataract Surgery Devices Market is estimated to reach $3.4 billion by 2028, growing at a CAGR of 7.5% over the forecast period 2023-2028. The cases of Primary angle closure glaucoma (PACG), which is more common than open angle glaucoma and has a higher possibility for blindness, are rising. Laser surgery is the most common method of angle closure. According to the National Library of Medicine (NLM), it was discovered that primary angle-closure (PAC) eyes with baseline peripheral anterior synechiae (PAS) less than two quadrants had an intraocular pressure (IOP) control rate of 89.8%, whereas if baseline PAS was greater than two quadrants, 62.7% of subjects were using medication. 

Researchers are using sophisticated laser cataract surgery to help glaucoma patients. With the right technical knowledge, experts can offer patients the advantages of cataract laser surgery, such as increased precision, better refractive results and less ultrasonic energy. They would surely be able to accomplish more in the future as the femtosecond laser system advances. Although glaucoma has been treated with lasers for many years, the right indications and use of the treatments must be taken into account before their use. The use of laser systems has simplified the process of treating glaucoma and most ophthalmologists frequently utilize these techniques, even at the most basic level, which in turn is promoting market expansion.

For More Queries About "Glaucoma & Cataract Surgery Devices Market" @ https://www.industryarc.com/support.php?id=502668

Glaucoma & Cataract Surgery Devices Market Drivers

• The Growth of the Aging Population who are More Vulnerable to Cataracts and Other Eye-Related Problems:

The need for cataract surgical tools is also being stimulated by people's growing awareness of the advantages of early detection and treatment of cataracts. In addition to this, the development of sophisticated cataract surgical tools such as forceps, speculum wire, Wescott scissors and calipers, as well as technical breakthroughs in ophthalmology like laser-assisted in situ keratomileusis (LASIK) surgery. According to LASIK Statistics data, the success rate for LASIK surgery is 96% across the industry and 90% of LASIK patients achieve 20/20 vision or better. In addition, the development of femtosecond laser technology is promoting market expansion.

• Demand for Glaucoma and Cataract Surgical Tools and Equipment:

Surgery for glaucoma and cataracts is frequently combined. The increased number of cataract operations is anticipated to directly boost the segment's expansion. Furthermore, the use of the minimal invasive glaucoma (MIGS) drainage tool, referred to as the iStent, in combination with cataract surgery was authorized. According to an article on Minimal Invasive Glaucoma (MIGS), after receiving an injection of an iStent, there was a 35–39% drop in intraocular pressure (IOP) and an improvement in medication usage. In around one year, 65-75% of individuals were entirely medication-free.

Additionally, glaucoma drainage devices (shunts, stents, implants and valves), laser systems, forceps, algerbrush, probes, diamond knives, USC markers, USC planners and USC shavers are utilized. Surgical tools like Forceps, algerbrush, probes, scissors, needle holders and diamond knives - all had respectable shares in glaucoma and cataract surgery devices market. With so many market participants, the surgical tools and equipment space is quite fragmented. The majority of customers choose to purchase goods from regional vendors as they can get more affordable devices and equipment. The market is anticipated to increase faster than average due to rising surgical device demand in developing nations.

R&D Investment:

In January 2022, Alcon acquired Ivantis, the business that created the ground-breaking Hydrus Microstent, a minimally invasive glaucoma treatment (MIGS) device. The surgical device aims to lower ocular pressure in patients with open-angle glaucoma. The company's repertoire of eye surgeries would grow as a result of this acquisition.

Major Players in Glaucoma and Cataract Surgery Devices Industry:

The major companies in the Glaucoma and Cataract Surgery Devices Industry include Alcon Inc, Allergan plc, Bausch & Lomb Inc, Carl Zeiss Meditec AG, Essilor International SA, HAAG-Streit Holding AG, Glaukos, Lumenis Ltd, Ziemer, Topcon Corporation and Others.502668